Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs aspirin in acute ischemic stroke or high-risk TIA
CTR20140730Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, transient ischaemic attack (TIA), sponsored by AstraZeneca. Started Nov 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on CTR20140730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140730.